151 related articles for article (PubMed ID: 9539837)
21. Predictive value of remnant-like particles cholesterol/high-density lipoprotein cholesterol ratio as a new indicator of coronary artery disease.
Masuoka H; Ishikura K; Kamei S; Obe T; Seko T; Okuda K; Koyabu S; Tsuneoka K; Tamai T; Sugawa M; Nakano T
Am Heart J; 1998 Aug; 136(2):226-30. PubMed ID: 9704682
[TBL] [Abstract][Full Text] [Related]
22. Apolipoprotein-B, low-density lipoprotein cholesterol, and the long-term risk of coronary heart disease in men.
St-Pierre AC; Cantin B; Dagenais GR; Després JP; Lamarche B
Am J Cardiol; 2006 Apr; 97(7):997-1001. PubMed ID: 16563904
[TBL] [Abstract][Full Text] [Related]
23. [Lp(a) and lipid order in a group of secondary school students selected according to their family anamnesis].
Postorino G; Altavilla R; Turchetti V; Leoncini F; Picciolini F; De Matteis C; Guerrini M; Forconi S
Minerva Med; 1994 Dec; 85(12):625-31. PubMed ID: 7854555
[TBL] [Abstract][Full Text] [Related]
24. Apolipoprotein B and non-high-density lipoprotein cholesterol are better risk markers for coronary artery disease than low-density lipoprotein cholesterol in hypertriglyceridemic metabolic syndrome patients.
Boumaiza I; Omezzine A; Rejeb J; Rebhi L; Kalboussi N; Ben Rejeb N; Nabli N; Ben Abdelaziz A; Boughazala E; Bouslama A
Metab Syndr Relat Disord; 2010 Dec; 8(6):515-22. PubMed ID: 20715933
[TBL] [Abstract][Full Text] [Related]
25. [Lipid Tetrad Index (LTI) and Lipid Pentad Index (LPI) in healthy subjects].
Morais CA; Oliveira SH; Lima LM
Arq Bras Cardiol; 2013 Apr; 100(4):322-7. PubMed ID: 23525271
[TBL] [Abstract][Full Text] [Related]
26. Paraoxonase-1 (PON1) activity in patients with coronary artery diseases and in diabetic patients.
Amine K; Atouk A; Moussamih S; Saile R; Mikou A; Kettani A
Ann Biol Clin (Paris); 2011; 69(6):671-7. PubMed ID: 22123566
[TBL] [Abstract][Full Text] [Related]
27. [Lipoprotein in children and adolescents: relationship with family history of coronary artery disease].
Casanueva V; Cid X; Calvo C; Chiang MT; Ulloa N; Milos C; Rodríguez W; Elgueta F
Rev Med Chil; 1996 Jul; 124(7):799-804. PubMed ID: 9138367
[TBL] [Abstract][Full Text] [Related]
28. [C-reactive protein as a new risk factor of coronary heart disease in the population of young Polish males].
Olszewski R; Grabysa R; Warmiński J; Makowski T; Szczechowicz R; Piechota W; Adamus J
Pol Merkur Lekarski; 2002 Jul; 13(73):14-7. PubMed ID: 12362497
[TBL] [Abstract][Full Text] [Related]
29. Correlation of lipoprotein (a) to angiographically defined coronary artery disease in Indians.
Gupta R; Vasisht S; Bahl VK; Wasir HS
Int J Cardiol; 1996 Dec; 57(3):265-70. PubMed ID: 9024915
[TBL] [Abstract][Full Text] [Related]
30. Lipoprotein and apoprotein A1 levels in diabetics and coronary heart disease patients and controls.
Pan XR; Hu SX; Gang Y; Jin L; Li XG; Li J; Yan Q; Chen TS
Chin Med J (Engl); 1987 Mar; 100(3):204-7. PubMed ID: 3113842
[No Abstract] [Full Text] [Related]
31. Lipid abnormalities in Greek patients with coronary artery disease.
Elisaf MS; Siamopoulos KC; Tselegarides TJ; Bairaktari ETh ; Goudevenos JA; Tselepis AD; Tsolas OE; Sideris DA
Int J Cardiol; 1997 Apr; 59(2):177-84. PubMed ID: 9158172
[TBL] [Abstract][Full Text] [Related]
32. [Paraoxonase 1 (PON1) activity and lipid parameters in Tunisian smokers].
Haj Mouhamed D; Ezzaher A; Araoud M; Neffati F; Douki W; Najjar MF
Ann Biol Clin (Paris); 2010; 68(2):143-7. PubMed ID: 20348046
[TBL] [Abstract][Full Text] [Related]
33. Relationship between bilirubin, apolipoprotein B, and coronary artery disease.
Levinson SS
Ann Clin Lab Sci; 1997; 27(3):185-92. PubMed ID: 9142370
[TBL] [Abstract][Full Text] [Related]
34. Plasma lipoprotein(a) values and severity of coronary artery disease in a large population of patients undergoing coronary angiography.
Labeur C; De Bacquer D; De Backer G; Vincke J; Muyldermans L; Vandekerckhove Y; Van der Stichele E; Rosseneu M
Clin Chem; 1992 Nov; 38(11):2261-6. PubMed ID: 1424121
[TBL] [Abstract][Full Text] [Related]
35. [Interpretation of B and A apoproteins dosage in the acute accidents of the cerebral and coronary atherosclerosis. Age influence upon the results (author's transl)].
Bugugnani MJ; Haiat R; Fouyé H; Rémy A; Desoutter P
Ann Biol Clin (Paris); 1981; 39(3):131-4. PubMed ID: 6787958
[TBL] [Abstract][Full Text] [Related]
36. Should we measure lipoprotein Lp(a)?
Wilson PW; Kannel WB
Arch Intern Med; 1997 Jun; 157(11):1161-2. PubMed ID: 9183225
[No Abstract] [Full Text] [Related]
37. [Serum lipid and lipoprotein levels in populations of Beijing].
Li JZ
Zhonghua Yi Xue Za Zhi; 1988 Jun; 68(6):327-31, 24. PubMed ID: 3228725
[No Abstract] [Full Text] [Related]
38. HDL and clinical and biochemical correlates in Italian non-smoker women.
Bigazzi F; Pino BD; Forastiere F; Pistelli R; Rossi G; Simoni M; Baldacci S; Viegi G; Bionda A; Sampietro T
Clin Chem Lab Med; 2004; 42(12):1408-16. PubMed ID: 15576304
[TBL] [Abstract][Full Text] [Related]
39. [Lipoprotein(a) and the cardiovascular risk during estrogen-progestin replacement therapy in postmenopause].
Porcelli A; Calleri L; Gallello D; Taccani C; Surico N
Minerva Ginecol; 1997; 49(1-2):39-42. PubMed ID: 9162884
[TBL] [Abstract][Full Text] [Related]
40. [Hypocholesterolemia in hematologic neoplasms].
Aixalá M; Sarandría CN; Speroni JG
Sangre (Barc); 1997 Feb; 42(1):7-10. PubMed ID: 9229806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]